Alcohol and Hydrocodone: Can You Take Them Together?

Critical — Potentially Dangerouscontraindication
Evidence-gradedLast reviewed June 1, 2026Source: FDA Zohydro ER (hydrocodone) Prescribing Information
Learn about each ingredient:AlcoholHydrocodone

Quick answer

Hydrocodone combined with alcohol produces dangerous additive CNS and respiratory depression with high risk of fatal overdose. Extended-release hydrocodone formulations can experience dose dumping when combined with alcohol, releasing the entire dose at once and causing potentially lethal blood concentrations.

Do not drink any alcohol while taking hydrocodone, including in combination products like Vicodin or Norco. The FDA boxed warning prohibits this combination because of fatal respiratory depression risk and dose dumping in extended-release products.

What happens when you take alcohol with hydrocodone?

Hydrocodone is a semi-synthetic opioid agonist that binds primarily to mu-opioid receptors in the central nervous system, producing analgesia, sedation, and dose-dependent respiratory depression. It is among the most commonly prescribed opioids in the United States, often in combination with acetaminophen as Vicodin or Norco. Like other opioids, hydrocodone depresses the respiratory control centers in the brainstem, slowing breathing rate and depth.

Alcohol is a separate central nervous system depressant that works through different mechanisms but produces similar effects. It enhances the activity of GABA, the brain's main inhibitory neurotransmitter, while suppressing glutamate, the main excitatory neurotransmitter. The net effect is widespread CNS depression including the same brainstem respiratory centers affected by hydrocodone. When the two substances are combined, the depressant effects compound, and breathing can slow to dangerous levels or stop entirely.

Extended-release hydrocodone formulations face an additional specific danger. Zohydro ER and Hysingla ER are designed to release hydrocodone gradually over 12 to 24 hours. Alcohol can disrupt the controlled-release mechanism of some of these tablets, causing dose dumping where the entire daily dose is released within minutes rather than gradually. This produces blood concentrations many times higher than intended, potentially fatal in opioid-naive patients. The FDA specifically issued warnings about this risk and required extensive testing of extended-release opioids for alcohol-induced dose dumping during development.

From a pharmacokinetic standpoint, hydrocodone is metabolized by CYP2D6 and CYP3A4 enzymes to active metabolites including hydromorphone, which is significantly more potent than hydrocodone itself. Alcohol affects multiple CYP enzymes and can alter metabolism patterns, producing unpredictable blood levels. Genetic variation in CYP2D6 means some people (ultra-rapid metabolizers) convert hydrocodone to hydromorphone very efficiently, producing higher than expected opioid effects.

Why is this important?

Hydrocodone combination products were until 2014 the most commonly prescribed medications in the United States. Although prescribing has decreased substantially as part of efforts to address the opioid crisis, hydrocodone remains widely used for moderate to severe acute pain after surgery, injury, or dental procedures. Many of these prescriptions are given to people who do not regularly use opioids and who may not understand the gravity of the alcohol interaction.

The FDA has placed a boxed warning, its strongest safety alert, on all hydrocodone-containing products. The warning specifically addresses concomitant alcohol use, stating that the combination may result in additive central nervous system depression, profound sedation, respiratory depression, coma, and death. The warning applies regardless of the alcohol source, including beer, wine, distilled spirits, alcohol-containing OTC medications such as cough syrups, mouthwashes, and herbal tinctures.

Opioid-related deaths in the United States peaked around 2017-2021 and remain very high. Alcohol is involved in a substantial fraction of these deaths. The CDC has reported that alcohol contributes to roughly one in five opioid overdose deaths. Hydrocodone-acetaminophen combinations are particularly dangerous because they combine three substances that interact problematically: hydrocodone and alcohol cause respiratory depression, while acetaminophen and alcohol cause liver toxicity.

Certain populations face especially elevated risk. Older adults metabolize both substances more slowly and have reduced respiratory reserve. People with sleep apnea, COPD, asthma, or other respiratory conditions have less margin for error. Opioid-naive individuals are at extreme risk because even modest doses can cause overdose when combined with alcohol. Those taking other CNS depressants, including benzodiazepines, sleep aids, muscle relaxants, gabapentin, or antihistamines, face cumulative risk.

What should you do?

If you have been prescribed hydrocodone in any form, the only safe approach is complete alcohol abstinence throughout the treatment period and for at least 24 hours after the last dose. Immediate-release hydrocodone has a half-life of about 4 hours, but extended-release formulations remain active much longer, requiring proportionally longer abstinence periods, ideally 48 hours.

If you are prescribed hydrocodone for acute pain after surgery or injury, plan in advance for an alcohol-free period. Most prescriptions for acute pain are short, typically a few days to a week, so abstinence during this window is feasible. If you have been prescribed hydrocodone for chronic pain and feel that you cannot give up alcohol, this is critical information for your prescriber. They may switch you to a non-opioid pain management strategy or refer you to addiction medicine support. Hiding alcohol use is dangerous because your prescriber cannot accurately assess overdose risk.

Read labels carefully on over-the-counter products. Many cough and cold remedies, NyQuil-type formulations, and herbal tinctures contain alcohol, sometimes at concentrations of 10 to 25 percent. Mouthwashes can contain up to 27 percent alcohol and pose a risk if swallowed. Communion wine, cooking with alcohol that has not fully evaporated, kombucha, and many other sources contain meaningful amounts of alcohol.

If you accidentally consume alcohol while on hydrocodone and notice excessive sedation, slow or shallow breathing, blue lips, pinpoint pupils, or unresponsiveness, this is a medical emergency. Call 911 and administer naloxone if available. Anyone with a prescription for opioids should have naloxone on hand, and household members should know how to use it. Naloxone is now available over the counter in the United States.

Which specific products are affected?

Hydrocodone is available in many products. Immediate-release combination products include Vicodin, Norco, Lortab, and many generics, all containing hydrocodone with acetaminophen in various ratios. Older combinations contained higher doses of acetaminophen (up to 750 mg), but the FDA limited combinations to 325 mg acetaminophen per dose in 2014 due to liver toxicity concerns. Hydrocodone with ibuprofen is sold as Vicoprofen, which adds NSAID-alcohol concerns to the opioid-alcohol concerns.

Extended-release hydrocodone products include Zohydro ER and Hysingla ER. These formulations are designed for severe chronic pain in opioid-tolerant patients and pose particular risk with alcohol due to dose dumping concerns. The FDA required Hysingla ER to demonstrate resistance to alcohol-induced dose dumping during approval, but no formulation is completely immune to this risk, and the boxed warning still applies.

Hydrocodone is also available in combination cough syrups, including hydrocodone-homatropine (Hycodan, Tussigon) and various combination cough preparations. These liquid formulations can be easy to dose imprecisely and have been targets of recreational abuse. Combining cough syrups containing hydrocodone with alcohol is especially dangerous and has caused fatalities.

The combination products with acetaminophen warrant specific mention. Norco and Vicodin combine hydrocodone with acetaminophen, and alcohol interactions occur with both components. The hydrocodone-alcohol interaction causes respiratory depression. The acetaminophen-alcohol interaction increases liver toxicity, particularly with chronic alcohol use or any binge drinking. Heavy drinkers on hydrocodone-acetaminophen combination products face risk of both respiratory failure and acute liver failure.

On the alcohol side, all sources matter. Standard alcohol drinks include beer (12 oz), wine (5 oz), and distilled spirits (1.5 oz), but craft beers and wines can contain significantly more alcohol per serving. Mixed drinks often contain multiple standard drinks. Even non-alcoholic beer contains up to 0.5 percent alcohol. Liquid medications containing ethanol as a solvent contribute to total intake. Herbal tinctures are typically 40 to 70 percent alcohol.

The bottom line

Hydrocodone combined with alcohol is among the most dangerous medication combinations in modern practice, capable of causing fatal respiratory depression at doses that would be tolerated separately. The FDA has issued its strongest possible warning against this combination. The risk applies to all hydrocodone formulations, including the very common Vicodin and Norco combinations with acetaminophen, the extended-release products with dose dumping concerns, and the cough syrups. If you are prescribed hydrocodone, you must not drink alcohol during treatment. The convenience of a drink is never worth the risk of fatal overdose. If alcohol abstinence feels difficult, this is critical information for your prescriber, who can discuss alternative pain management approaches and support resources.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Alcohol + Gabapentin

high

Gabapentin and alcohol are both central nervous system depressants. The FDA issued a 2019 Drug Safety Communication warning that gabapentin can cause serious, potentially fatal respiratory depression when combined with CNS depressants including alcohol, particularly in older adults and patients with respiratory disease.

Alcohol + Pregabalin

high

Pregabalin (Lyrica) and alcohol are both central nervous system depressants with additive effects on sedation, coordination, and respiratory drive. The FDA's 2019 Drug Safety Communication warned that pregabalin can cause life-threatening respiratory depression when combined with CNS depressants such as alcohol, particularly with opioids or in patients with lung disease.

Alcohol + Alprazolam

critical

Alcohol and alprazolam (Xanax) both depress the central nervous system through GABA-A receptor potentiation, producing additive sedation, profound respiratory depression, and impaired psychomotor function. The combination significantly increases risk of overdose death, even at moderate doses of each substance.

Alcohol + Diazepam

critical

Diazepam (Valium) and alcohol are both GABA-A receptor positive allosteric modulators, producing additive and supra-additive CNS depression with profound risk of respiratory depression, coma, and death. Diazepam's long half-life and active metabolites extend the window of dangerous interaction far beyond the dosing interval.

Alcohol + Kava

high

Kava and alcohol both depress the central nervous system through GABAergic and other mechanisms, producing additive sedation and motor impairment. More importantly, both substances are hepatotoxic, and concurrent use significantly increases the risk of severe liver injury, including cases of fulminant liver failure requiring transplantation.

Alcohol + Lithium

high

Lithium has a narrow therapeutic window and is excreted by the kidneys. Alcohol causes diuresis and dehydration, which reduces renal lithium clearance and raises serum lithium levels — pushing patients toward lithium toxicity (tremor, confusion, ataxia, arrhythmia). Alcohol also worsens mood instability in bipolar disorder.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free